Successfully navigating the regulatory hoops becomes even more complicated depending on the market in which manufacturers hope to launch their product.
As healthcare investors consider their next move in today’s fast-moving deal market, there are myriad issues and opportunities at the top of their agenda.
The incorporation of biomedical textiles in medical devices is enabling procedures across a wide range of surgical markets to be simpler and less invasive.
Given the scramble to address supply chain challenges, this year might be an ideal time for medtech firms to re-evaluate ways to generate new business.